Portfolio (Quarterly)
Guide ↗
Avoro Capital Advisors LLC
· CIK 0001633313| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 21,700,000.0 | $119.3M | 1.17% | NEW | — | $5.50 | -14.0% |
| 22 | — | MIND MEDICINE (MINDMED) INC | — | 5,000,000.0 | $67.0M | 0.66% | NEW | — | $13.39 | — |
| 23 | PTCT | PTC THERAPEUTICS INC | Healthcare | 685,000.0 | $52.0M | 0.51% | NEW | — | $75.96 | -16.7% |
| 24 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 1,500,000.0 | $46.7M | 0.46% | NEW | — | $31.12 | -35.0% |
| 25 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 1,333,340.0 | $40.4M | 0.40% | NEW | — | $30.31 | +178.9% |
| 26 | ALKS | ALKERMES PLC | Healthcare | 1,400,000.0 | $39.2M | 0.39% | NEW | — | $27.98 | +45.3% |
| 27 | — | APOGEE THERAPEUTICS INC | — | 500,000.0 | $37.7M | 0.37% | NEW | — | $75.48 | — |
| 28 | SEPN | SEPTERNA INC | Healthcare | 1,337,500.0 | $37.3M | 0.37% | NEW | — | $27.88 | +36.0% |
| 29 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 3,300,000.0 | $32.8M | 0.32% | NEW | — | $9.93 | -66.9% |
| 30 | MNKD | MANNKIND CORP | Healthcare | 4,444,444.0 | $25.2M | 0.25% | NEW | — | $5.67 | -42.3% |
| 31 | GHRS | GH RESEARCH PLC | Healthcare | 1,800,000.0 | $22.9M | 0.23% | NEW | — | $12.70 | +85.8% |
| 32 | INCY | INCYTE CORP | Healthcare | 135,000.0 | $13.3M | 0.13% | NEW | — | $98.77 | +25.4% |
| 33 | WHWK | WHITEHAWK THERAPEUTICS INC | Healthcare | 2,849,402.0 | $6.9M | 0.07% | NEW | — | $2.42 | +56.0% |
| 34 | — CALL | ASCENDIS PHARMA | — | 50,000.0 | $625K | 0.01% | NEW | — | $12.50 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%